Bio-Techne
TECH
#1486
Rank
S$15.75 B
Marketcap
$99.15
Share price
2.49%
Change (1 day)
-3.82%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.80 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are S$0.80 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30S$0.91 B10.24%
2022-06-30S$0.82 B-11.1%
2021-06-30S$0.93 B3.28%
2020-06-30S$0.90 B-7.38%
2019-06-30S$0.97 B38.77%
2018-06-30S$0.70 B-16.47%
2017-06-30S$0.83 B148.9%
2016-06-30S$0.33 B15.62%
2015-06-30S$0.29 B246.97%
2014-06-30S$84.01 M63.47%
2013-06-30S$51.39 M-9.63%
2012-06-30S$56.86 M46.2%
2011-06-30S$38.89 M63.29%
2010-06-30S$23.82 M6.02%
2009-06-30S$22.46 M-18.29%
2008-06-30S$27.5 M4.28%
2007-06-30S$26.37 M-44.75%
2006-06-30S$47.72 M3.4%
2005-06-30S$46.15 M-4.32%
2004-06-30S$48.24 M3.07%
2003-06-30S$46.8 M-16.54%
2002-06-30S$56.08 M-18.73%
2001-06-30S$69.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$69.46 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.22 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$42.54 B 5,155.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$39.71 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.71 B 358.71%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$145.80 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$40.18 M-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA